Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$76.72 - $92.68 $2.34 Million - $2.82 Million
-30,459 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$76.02 - $88.62 $7,449 - $8,684
-98 Reduced 0.32%
30,459 $2.41 Million
Q2 2021

Aug 11, 2021

SELL
$73.44 - $87.01 $790,948 - $937,097
-10,770 Reduced 26.06%
30,557 $2.57 Million
Q1 2021

May 14, 2021

SELL
$62.9 - $82.41 $3.69 Million - $4.84 Million
-58,698 Reduced 58.68%
41,327 $3.04 Million
Q4 2020

Feb 11, 2021

SELL
$46.01 - $68.74 $8.21 Million - $12.3 Million
-178,394 Reduced 64.07%
100,025 $6.7 Million
Q3 2020

Nov 12, 2020

SELL
$41.91 - $57.81 $431,966 - $595,847
-10,307 Reduced 3.57%
278,419 $12.6 Million
Q2 2020

Aug 12, 2020

BUY
$39.87 - $56.9 $11.5 Million - $16.4 Million
288,726 New
288,726 $13.9 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Brandes Investment Partners, LP Portfolio

Follow Brandes Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.